ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences

Private equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bidder Nirma. Along with Nirma and ChrysCapital, Sekhmet Pharmaventures backed by PE firms PAG, CX Partners and Samara Capital also in the list of potential investors in the race to acquire Glenmark Pharma stake in GLS.

Related Keywords

Samara ,Samarskaya Oblast ,Russia ,India ,Sekhmet Pharmaventures ,Glenmark Pharma ,Exchange Board Of India ,Glenmark Life Sciences ,Exchange Board ,Samara Capital ,Chryscapital Still ,Buy Controlling Stake ,Nirma ,Glenmark ,Chryscapital ,Pharma ,Securities And Exchange Board Of India ,